Literature DB >> 23201308

Alteration to hippocampal shape in cannabis users with and without schizophrenia.

Nadia Solowij1, Mark Walterfang, Dan I Lubman, Sarah Whittle, Valentina Lorenzetti, Martin Styner, Dennis Velakoulis, Christos Pantelis, Murat Yücel.   

Abstract

Abnormalities in hippocampal morphology are characteristic of schizophrenia and have also been reported in chronic cannabis users. There is a paucity of research investigating potential additive effects of cannabis use on brain pathology associated with schizophrenia. In this study, we performed hippocampal shape analysis in cannabis-using and non-using patients with schizophrenia, healthy cannabis users and healthy non-using controls. Hippocampal shape changes were observed in each group relative to controls, with the greatest degree of alterations (i.e., deflations across the hippocampus, and with an anterior predisposition), in cannabis-using schizophrenia patients. These alterations were associated with cannabis use patterns and psychotic symptoms.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23201308     DOI: 10.1016/j.schres.2012.10.040

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  28 in total

1.  Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users.

Authors:  Yann Chye; Nadia Solowij; Chao Suo; Albert Batalla; Janna Cousijn; Anna E Goudriaan; Rocio Martin-Santos; Sarah Whittle; Valentina Lorenzetti; Murat Yücel
Journal:  Psychopharmacology (Berl)       Date:  2017-04-01       Impact factor: 4.530

2.  Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies.

Authors:  Valentina Lorenzetti; Yann Chye; Pedro Silva; Nadia Solowij; Carl A Roberts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-01-31       Impact factor: 5.270

3.  Impact of substance use disorder on gray matter volume in schizophrenia.

Authors:  Margaret Quinn; Maureen McHugo; Kristan Armstrong; Neil Woodward; Jennifer Blackford; Stephan Heckers
Journal:  Psychiatry Res Neuroimaging       Date:  2018-08-03       Impact factor: 2.376

Review 4.  Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings.

Authors:  Kaloyan Rumenov Stoychev
Journal:  Front Psychiatry       Date:  2019-10-23       Impact factor: 4.157

5.  Cannabis-related hippocampal volumetric abnormalities specific to subregions in dependent users.

Authors:  Yann Chye; Chao Suo; Murat Yücel; Lauren den Ouden; Nadia Solowij; Valentina Lorenzetti
Journal:  Psychopharmacology (Berl)       Date:  2017-04-19       Impact factor: 4.530

Review 6.  Cannabis and Psychosis: a Critical Overview of the Relationship.

Authors:  Charles Ksir; Carl L Hart
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

7.  Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.

Authors:  Christian Núñez; Susana Ochoa; Elena Huerta-Ramos; Iris Baños; Ana Barajas; Montserrat Dolz; Bernardo Sánchez; Núria Del Cacho; Judith Usall
Journal:  Psychopharmacology (Berl)       Date:  2015-12-01       Impact factor: 4.530

8.  Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjects.

Authors:  Matthew J Smith; Derin J Cobia; James L Reilly; Jodi M Gilman; Andrea G Roberts; Kathryn I Alpert; Lei Wang; Hans C Breiter; John G Csernansky
Journal:  Hippocampus       Date:  2015-03-11       Impact factor: 3.899

9.  Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.

Authors:  Ameer Y Taha; Yewon Cheon; Kaizong Ma; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Psychiatr Res       Date:  2013-02-18       Impact factor: 4.791

Review 10.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.